Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient access to perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin and docetaxel in patients with resectable gastric cancer in the Netherlands.
Geerts JFM, Pape M, Vissers PAJ, Verhoeven RHA, Mostert B, Wijnhoven BPL, Rosman C, van Hellemond IEG, Nieuwenhuijzen GAP, van Laarhoven HWM. Geerts JFM, et al. Among authors: van hellemond ieg. Eur J Cancer. 2025 Jan;214:115137. doi: 10.1016/j.ejca.2024.115137. Epub 2024 Nov 20. Eur J Cancer. 2025. PMID: 39591847
Metagenomic analysis during capecitabine therapy reveals microbial chemoprotective mechanisms and predicts drug toxicity in colorectal cancer patients.
Hillege LE, Trepka KR, Ziemons J, Aarnoutse R, Guthrie BGH, de Vos-Geelen J, Valkenburg-van Iersel L, van Hellemond IEG, Baars A, Vestjens JHMJ, Penders J, Deutschbauer A, Atreya CE, Kidder WA, Turnbaugh PJ, Smidt ML. Hillege LE, et al. Among authors: van hellemond ieg. medRxiv [Preprint]. 2024 Oct 15:2024.10.11.24315249. doi: 10.1101/2024.10.11.24315249. medRxiv. 2024. PMID: 39484258 Free PMC article. Preprint.
Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial.
Lammers SWM, Geurts SME, Hermans KEPE, van Hellemond IEG, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, Honkoop AH, van den Berkmortel FWPJ, de Roos WK, Imholz ALT, Vriens IJH, Tjan-Heijnen VCG; Dutch Breast Cancer Research Group (BOOG) for the DATA investigators. Lammers SWM, et al. Among authors: van hellemond ieg. Breast Cancer Res Treat. 2024 Nov;208(1):179-192. doi: 10.1007/s10549-024-07411-w. Epub 2024 Jun 28. Breast Cancer Res Treat. 2024. PMID: 38940981 Free PMC article. Clinical Trial.
Dutch national guidelines for locally recurrent rectal cancer.
Piqeur F, Creemers DMJ, Banken E, Coolen L, Tanis PJ, Maas M, Roef M, Marijnen CAM, van Hellemond IEG, Nederend J, Rutten HJT, Peulen HMU, Burger JWA. Piqeur F, et al. Among authors: van hellemond ieg. Cancer Treat Rev. 2024 Jun;127:102736. doi: 10.1016/j.ctrv.2024.102736. Epub 2024 Apr 19. Cancer Treat Rev. 2024. PMID: 38696903 Review.
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
van de Vlasakker VCJ, Guchelaar NAD, van den Heuvel TBM, Lurvink RJ, van Meerten E, Bax RJF, Creemers GM, van Hellemond IEG, Brandt-Kerkhof ARM, Madsen EVE, Nederend J, Koolen SLW, Nienhuijs SW, Kranenburg O, de Hingh IHJT, Verhoef C, Mathijssen RHJ, Burger JWA; Dutch Peritoneal Oncology Group; Dutch Colorectal Cancer Group. van de Vlasakker VCJ, et al. Among authors: van hellemond ieg. BMJ Open. 2024 Jan 18;14(1):e077667. doi: 10.1136/bmjopen-2023-077667. BMJ Open. 2024. PMID: 38238055 Free PMC article.
ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone for the PREOPANC-4 Trial.
Stoop TF, Seelen LWF, van 't Land FR, van Eijck CHJ, van Santvoort HC, Besselink MG; Dutch Pancreatic Cancer Group. Stoop TF, et al. Ann Surg Oncol. 2024 Apr;31(4):2658-2659. doi: 10.1245/s10434-023-14704-9. Epub 2023 Dec 13. Ann Surg Oncol. 2024. PMID: 38093164 No abstract available.
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
Lammers SWM, Geurts SME, van Hellemond IEG, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, de Roos WK, Linn SC, Imholz ALT, Smidt ML, Vriens IJH, Tjan-Heijnen VCG. Lammers SWM, et al. Among authors: van hellemond ieg. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad092. doi: 10.1093/jncics/pkad092. JNCI Cancer Spectr. 2023. PMID: 37991939 Free PMC article. Clinical Trial.
Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapy.
Nordkamp S, Piqeur F, van den Berg K, Tolenaar JL, van Hellemond IEG, Creemers GJ, Roef M, van Lijnschoten G, Cnossen JS, Nieuwenhuijzen GAP, Bloemen JG, Coolen L, Nederend J, Peulen HMU, Rutten HJT, Burger JWA. Nordkamp S, et al. Among authors: van hellemond ieg. Br J Surg. 2023 Jul 17;110(8):950-957. doi: 10.1093/bjs/znad094. Br J Surg. 2023. PMID: 37243705
30 results